Form D Explorer

Inspect source fieldsReport a record issue

Form D — Slate Medicines, Inc.

0001231919-26-000246 · filed Mar 11, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$130,000,000
Reported amount sold
$9,999,992
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Slate Medicines, Inc.
CIK
2117806
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
200 BERKELEY STREET, 18TH FLOOR
BOSTON, Massachusetts 02116
Phone
(617) 778-2500

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗